Epogen/Procrit, Procrit (epoetin alfa) is a protein pharmaceutical. Epoetin alfa was first approved as Epogen/Procrit on 1989-06-01. It is used to treat anemia in the USA. It has been approved in Europe to treat anemia, chronic kidney failure, and neoplasms. It is known to target erythropoietin receptor.
|Trade Name||Epogen/Procrit, Procrit|
|Common Name||Epoetin alfa|
|Indication||anemia, chronic kidney failure, neoplasms|